1.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: KA05028-MA, KA05028, NCT00114829
|
|
2.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DM01VEN/4/03, NCT00199277
|
|
3.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000454401, GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
|
|
4.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 004907, NCT00626054
|
|
5.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 75 and over Sponsor: Other Protocol IDs: I07028, N° EudraCT : 2008-001195-7, NCT00812864
|
|
6.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 74 Sponsor: Other Protocol IDs: 2009-03, NCT00868569
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2009-04, NCT00874406
|
|
8.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: Oxali04882, NCT01023633
|
|
9.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-041, NCT01169220
|
|
10.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 20110101, NCT01307878
|
|
11.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DERMATUX, NCT01315990
|
|
12.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PROFUSE-2011, NCT01468623
|
|
13.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-008104, NCT01471756
|
|
14.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GEMCAD-1006, NCT01493713
|
|
15.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 40 and over Sponsor: Other Protocol IDs: ASAPOL, NCT01549418
|
|
16.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 170/11, NCT01552291
|
|
17.
|
Phase: Phase IV Type: Screening Status: Active Age: 40 to 65 Sponsor: Other Protocol IDs: CEC_cribado_CCR, NCT01557101
|
|
18.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2012-03, NCT01564810
|
|
19.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML25753, NCT01588990
|
|
20.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDS - APQ-01005-11, NCT01609660
|
|
21.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HBB-1, NCT01609855
|
|
22.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: SG 343/12, NCT01641458
|
|
23.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PRECOL2011-1, 2011-000587-10, NCT01649674
|
|
24.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: AMT/P2CA/001, LC003AURON2005, NCT00332280
|
|
25.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: AMT/P2GI/001 Part III, LC001Auron2005, NCT00405561
|